NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
The INS Winter Meeting heard a presentation on rare kidney stone disease identification, treatment, and prevalence from Consultant Nephrologist at the Royal Free Hospital, London, Dr Shabbir Moochhala.
Dr Moochhala said kidney stones are “neglected, I think, from a nephrology point of view”. He recommended a “quick screen of all patients” when they present with kidney stones.
Dr Moochhala also said it was important to determine the age of the patient when they got their first stone, the recurrence rate, and then a sample for testing to detect rare stones.
Genetic conditions can also cause stone formation; however, this only solves about 15 per cent of stones in monogenic conditions and 50 per cent of stones in polygenic conditions.
“It is not about just looking at genetics, it’s not about looking at biochemistry, it’s about looking at the patient,” said Dr Moochhala.
Paraphrasing one of his mentors, he added: “When you look back at the history of tubulopathies and a lot of other conditions, a lot of these were discovered by… just old-style clinical medicine, looking at patients and categorising them, [and] understanding what’s going on.”
According to Dr Moochhala, “rare stones are really worth diagnosing” because they “are often treatable”.
“And even if you don’t make a rare disease diagnosis, by controlling them more or reducing the risk, you’re helping the patients, [and] you’re also diagnosing cardiovascular disease.”
Knowing when to refer to a specialist is also important, Dr Moochhala added. He recommended referral in cases where stones develop under the age of 30, the stones are bilateral, it is a rare stone type, and there is unexplained chronic kidney disease.
Speaking to the Medical Independent, he said: “By giving patients a diagnosis [and] by enabling them to even self-manage sometimes, where appropriate, we can take the pressure off the health services by preventing them from having either episodes of acute kidney injury or stones,” he said.
“That’s really what it’s about in terms of trying to reduce the number of acute attendances at hospital; that will help the patients and the health service.”
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Hundreds of delegates will gather next month for a seminal meeting in the calendar of the...
IHCA members have called on the Government to address the “historic underfunding and lack of capital...
ADVERTISEMENT
There is a lot of publicity given to the Volkswagen Golf, which is celebrating 50 years...
As older doctors retire, a new generation has arrived with different professional and personal priorities. Around...
Catherine Reily examines the growing pressures in laboratory medicine and the potential solutions,with a special focus...
The highlight of this year’s Irish Society for Rheumatology (ISR) Autumn Meeting was undoubtedly the...
ADVERTISEMENT
ADVERTISEMENT
Leave a Reply
You must be logged in to post a comment.